Home » Newsletters » BioWorld Science

BioWorld Science

July 15, 2011

View Archived Issues

Pfizer claims novel agents for Gram-negative bacterial infections

Celecoxib may prevent lung cancer development/progression in former smokers

Metabolic Solutions Development begins phase II trial of MSDC-0160 in Alzheimer's disease

Final HORIZONS-AMI data favor bivalirudin and Taxus paclitaxel-eluting stent in STEMI

Evotec discloses new voltage-gated K(V)1.3 potassium channel blockers

Servier patents novel histamine H3 receptor antagonists

Novel GC-C agonists disclosed by Ironwood Pharmaceuticals

Everolimus improves response to trastuzumab in metastatic breast cancer

Celprogen's neuronal trans-differentiated stem cells show promise in models of Alzheimer's disease

Cardioxyl and Johns Hopkins University synthesize new nitroxyl donors

Aslan Pharmaceuticals licenses ARRY-543 from Array BioPharma

PU-H71 enters first-in-human phase I study in advanced malignancies

Lupus treatment Benlysta gains European marketing approval

Novel nNOS inhibitor displays potent analgesic effects in preclinical tests

Phase II trial shows aviscumine may improve survival in metastatic melanoma

OncoVista Innovative Therapies begins additional animal safety study of OVI-117

FDA's ODAC recommends accelerated approval of Adcetris for Hodgkin's lymphoma and ACLC

BioMarin's BMN-673 enters phase I trial in advanced hematological malignancies

Chugai seeks Japanese approval of Pulmozyme to improve pulmonary function in cystic fibrosis

Evolva completes phase I studies of EV-077

Vical and Astellas Pharma enter worldwide license agreements for TransVax cytomegalovirus vaccine

Pertuzumab/trastuzumab/docetaxel improves progression-free survival in HER2+ breast cancer

Development of Impax's IPX-066 for Parkinson's disease supported by Michael J. Fox Foundation grant

Biotec Pharmacon reports phase I/II data on SBG/3F8 combination in pediatric neuroblastoma

FDA issues complete response letter for resubmitted Intermezzo NDA

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
First phase of synthetic human genome project successfully completes
BioWorld
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Laigo raises €11.5M seed money for targeted protein degradation
BioWorld Science
Laigo Bio BV has raised €11.5 million (US$13.7 million) in a seed round for the further development of a new approach to inducing targeted protein degradation by...